The 2nd Annual Cancer Immunotherapy Conference

About This Activity

Arrowhead’s 2nd Annual Cancer Immunotherapy Conference will provide a comprehensive review of cutting edge research and development in two areas: Cancer stem cells as a new category of targets for immune intervention for solid and hematological malignancies Hematopoietic stem cell and T cell engineering for cancer immunotherapy \nThe conference is bringing together leading scientists and C-Level executives from across the globe to present research, case studies and viewpoints on topics related to stem cells and cancer immunotherapy.

Discuss This Activity

This activity has passed